Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 2/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17821298 | 1.00 | PDPK1 (0.42) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL3859887 | 1.00 | PDPK1 (0.42) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL14180109 | 1.00 | PDPK1 (0.42) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL13683691 | 1.00 | PDPK1 (0.42) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL3867701 | 1.00 | PDPK1 (0.42) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL17827490 | 1.00 | PDPK1 (0.42) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL7833562 | 0.93 | PDPK1 (0.41) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL14180112 | 0.92 | PDPK1 (0.43) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL8690255 | 0.90 | PDPK1 (0.41) | PDPK1MTORIDO1BCHEMEN1 | |
| SCHEMBL14180110 | 0.90 | PDPK1 (0.41) | PDPK1MTORIDO1BCHEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7589072-B2 | Inositol-based molecular transporters and processes for the preparation thereof | POSTECH FOUNDATION (KR) | 2009-09-15 | — | — | US | disclosed |
| US-20060280796-A1 | Inositol-based molecular transporters and processes for the preparation thereof | POSTECH FOUNDATION (KR) | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060280796-A1 | Inositol-based molecular transporters and processes for the preparation thereof | SLC2A8, SLC2A1, SLC29A2 | PDPK1 405/4885MTOR 1425/4885IDO1 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.